RxDoctor Payments Data

Lisa Chipps, MD

MOHS-Micrographic Surgery · Beverly Hills, CANPI 1689720278

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 201 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 35 manufacturers, the largest accounting for just 13.8% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2024 at $1,642 and has fallen 57.8% since, to $694 in 2025.

$4,895in general payments, 2019–2025

Across 201 payments — averaging $24.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • E.r. Squibb & Sons, L.L.C.$674
  • Regeneron Healthcare Solutions, Inc.$501
  • AbbVie$478
  • Sun Pharmaceutical Industries Inc.$474
  • Strata Skin Sciences, Inc.$365
  • Pfizer$326
  • plus $2K from 29 others

What the payments were for

  • Food & beverage$4,895100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,895 in reported general payments places this provider in the 70th percentile of 144 mohs-micrographic surgery providers in California.

See all mohs-micrographic surgery providers in California

Medicare billing

Part B allowed, 2024
$687,012
Medicare patients
737
Services billed
4,396

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Fluorouracil19$1,466
Doxycycline Hyclate31$1,274
Ketoconazole57$1,083
Tretinoin17$1,077
Betamethasone Dipropionate12$1,048
ValacyclovirValacyclovir Hcl26$561
Triamcinolone Acetonide49$364
Cephalexin29$344
Econazole Nitrate11$197
Mupirocin37$156

Paid to pharmacies, not to this prescriber.

Other mohs-micrographic surgery in Beverly Hills

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →